Advanced Stage NSCLC

Sort by:
Relevance Thumbs Up Comments Views Newest Oldest
08:44

Insights from ELCC 2025

ELCC 2025 Insights: Evaluating Survival & Treatment Outcomes in NSCLC - A SEER Database Analysis of Demographic, Socioeconomic, and Clinical Factors

FEATURING Mai Abdelkader Mohamed Abdelrasheed
  • 1 view
  • April 17, 2025
19:01

Insights from ELCC 2025

ELCC 2025 Summary: Overcoming Primary Resistance to NSCLC Immunotherapy

FEATURING Roberto Ferrara
  • 1 view
  • April 17, 2025
08:27

Insights from ELCC 2025

ELCC 2025 Insights: Does Timing of IO Infusion Influence Clinical Outcomes in Advanced NSCLC?

FEATURING Ivánia Furtado
  • April 17, 2025
08:40

Insights from ELCC 2025

ELCC 2025 Insights: Predictors of Multidisciplinary Tumor Board Adherence in Stage III NSCLC Patients From a Large Multicenter Study

FEATURING Markus Joerger
  • April 17, 2025
06:48

Insights from ELCC 2025

ELCC 2025 Insights: PACIFIC Trial Analysis - Differential Effect of PPIs & Antibiotics on Clinical Outcomes From IO or Placebo in Stage 3 Unresectable NSCLC Patients Who Have Not Progressed Following CRT

FEATURING Leonardo Brunetti
  • 1 view
  • April 17, 2025
08:13

Insights from ELCC 2025

ELCC 2025 Insights: Phase 2 Study of Telomere-Targeting Agent THIO Sequenced by Cemiplimab in ICI-Resistant Advanced NSCLC - Interleukin-6 as a Potential Predictive Biomarker

FEATURING Tomasz Jankowski
  • April 17, 2025
32:06

Insights from ELCC 2025

ELCC 2025 Summary: Monday Morning Practice - MARIPOSA Highlights & Frontline Advanced EGFRm NSCLC Management

FEATURING Balazs Halmos
  • 8 views
  • April 15, 2025
  • 1
10:07

Catherine Shu

Managing Cutaneous Toxicities in EGFRm NSCLC: Insights From Amivantamab Use

  • 2 views
  • April 15, 2025
04:54

Insights from ELCC 2025

ELCC 2025 Summary: Highlights From the Recent Advanced NSCLC Trials - MARIPOSA, COCOON, SOHO-01, & KROCUS

FEATURING Bjørn Henning Grønberg
  • 18 views
  • April 14, 2025
  • 1
03:24

ecancer

ELCC 2025 Insights: KEYNOTE-799 - Pembro + cCRT in Unresectable Locally Advanced NSCLC

FEATURING Martin Reck
  • 4 views
  • April 14, 2025
06:30

Insights from ELCC 2025

ELCC 2025 Insights: Real-World Understanding of the Analytical Performance of NGS for HER2 Mutation Detection in NSCLC

FEATURING Fernando Schmitt
  • 12 views
  • April 11, 2025
13:14

Insights from ELCC 2025

ELCC 2025 Summary: Managing Locally Advanced NSCLC With Poor Lung Function - The Role of RT in the Era of IO

FEATURING Corinne Faivre-Finn
  • 2 views
  • April 11, 2025
04:10

ecancer

ELCC 2025 Insights: Phase I/II SOHO-01 Study of BAY 2927088 in Patients With Previously Treated HER2-Mutant NSCLC

FEATURING Nicolas Girard
  • 3 views
  • April 11, 2025
03:01

ecancer

ELCC 2025 Summary: Preventing Moderate to Severe Dermatologic AEs in 1L EGFRm Advanced NSCLC Treated With Amivantamab + Lazertinib

FEATURING Nicolas Girard
  • 8 views
  • April 11, 2025
06:03

ecancer

ELCC 2025 Insights: Phase 3 MK-3475A-D77 Trial - SC vs. IV Pembro + Chemo in mNSCLC

FEATURING Enriqueta Felip
  • 4 views
  • April 11, 2025
12:21

Insights from ELCC 2025

ELCC 2025 Insights: Pembro + CCRT in Unresectable Locally Advanced NSCLC - Final Analysis of KEYNOTE-799

FEATURING Sara Ramella
  • 44 views
  • April 9, 2025
10:01

Insights from ELCC 2025

ELCC 2025 Insights: Osimertinib After Definitive CRT for Unresectable Stage 3 EGFRm NSCLC - Updated OS Analysis From the LAURA Study

FEATURING Sara Ramella
  • 17 views
  • April 9, 2025
14:56

Yale Cancer Center

Decoding ROS1 Fusion-Positive NSCLC: From Diagnosis to Targeted Therapy

FEATURING Amin Nassar
  • 20 views
  • April 9, 2025
11:27

Insights from ELCC 2025

ELCC 2025 Insights: The TNM Stage Classification of Thymic Tumors Replacing Masaoka Stage System - Old Habits Die Hard

FEATURING Edith Marom
  • 4 views
  • April 9, 2025
16:41

Insights from ELCC 2025

ELCC 2025 Summary: Targeted Treatment of RAS-Mutant NSCLC: Adagrasib + Pembro or Fulzerasib + Cetuximab for 1L KRAS G12C; Daraxonrasib Monotherapy for 2L+ Pan-RAS G12X-Cm+ Disease

FEATURING Joop Langen
  • 9 views
  • April 9, 2025
88:00

The Immuno-Oncology Clinical Network (IOCN)

Cases of Immune-Related Hepatitis and Cholangitis in Melanoma and NSCLC

FEATURING Anna Olsson-Brown, Guy Kendall, Ricky Frazer, Trudy Guinan, Lucia Possamai, Claire Barlow
  • 11 views
  • April 4, 2025
11:03

OncoPharm

FDA Approval of Zenocutuzumab for NRG1 Fusion-Positive mNSCLC and mPDAC: Drug and Toxicity Overview

FEATURING John Bossaer
  • 5 views
  • April 3, 2025
05:35

COR2ED The Heart of Medical Education

ELCC 2025 Summary: EGFRm and HER2-Mutated/Overexpressing Advanced NSCLC Updates From Recent Trials

FEATURING Nicolas Girard
  • 31 views
  • April 2, 2025
21:58

GRACE

Reading a Molecular Testing Report in Lung Cancer

FEATURING Karen Yun
  • 35 views
  • April 1, 2025
  • 1
18:32

GRACE

ALK, ROS1, and RET in NSCLC: Pushing the Boundaries of Targeted Therapies

FEATURING Christine Bestvina
  • 38 views
  • April 1, 2025
  • 1

Advanced Stage NSCLC

Recommended Topics:

Stage 3 NSCLC Stage 4 NSCLC

All Topics: